טוען...

O30 Variation in immunosuppressant impact on severe COVID-19 outcome: preliminary results from the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19)

Background/Aims  The novel infectious disease COVID-19 is associated with a wide spectrum of clinical severity amongst the general population. Patients with autoimmune rheumatic diseases (ARD) are more likely to experience serious COVID-19 related events, although risk factors for such outcomes have...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Rheumatology (Oxford)
Main Authors: Karabayas, Maira, Brock, James, Rutherford, Matthew, Fordyce, Gillian, Fluck, Nick, Kardash, Sally, Moran, Lucy, Richmond, Ruth, Tan, Adrian, Sznajd, Jan, Lambie, Stewart, Khalid, Mohmmed, Else, Sara, Davies, Carol A, Duncan, Margaret, Mclaren, John, Duncan, Sean, Murphy5, Sean, Hasan, Fuad, Basu, Neil
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2021
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8135447/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keab246.029
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!